Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
About the venue
Rooms
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Register now
days
hours
minutes
seconds
Programme
Africa
Alcohol
Asia
Basic research
Behavioural addictions
Cannabis
Capacity-building
Civil society
Clinical research/practice
Comorbidity
COVID-19
Criminal justice/prisons
Criminology
Drug user's perspectives
E-health/digitalisation
ECR (Early Career Researchers)
Europe
Gender perspectives
Harm reduction
Health inequalities
Hepatitis
HIV
Infectious diseases
Markets
Mental health and wellbeing
Monitoring and evaluation
Neuroscience
New psychoactive substances
Nicotine/tobacco
North America
Oceania
Opiates
Overdose
Policy
Prescription drugs
Prevention
Psychostimulants
Public health
Qualitative methods
Quantitative methods
Recreational setting
Risky behaviours
South America
Toxicology and forensic analysis
Treatment
Underrepresented groups
Workforce
Youth/children
Apply
Reset
WED
23 OCT
THU
24 OCT
FRI
25 OCT
Filter by sessions
All
Plenary session
Big debate
Major session
Workshop
Oral presentation session
Short communication session
e-short communication session
e-poster session
Video contest
PDF version
Wed 23 Oct
08:00
Arrival and registration
08:00
to
08:30
Break
08:30
Official opening
08:30
to
09:00
Auditorium I
Plenary session
09:00
Meeting the needs of service users and service providers
Plenary 1
09:00
to
10:30
Auditorium I
Plenary session
e-poster session day 1
09:00
to
18:20
Digital kiosks
e-poster session
e-short communication session day 1
09:00
to
18:20
Digital kiosks
e-short communication session
10:30
Coffee break
10:30
to
10:50
Break
10:50
Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research
10:50
to
12:20
Auditorium I
Major session
Advances in drug treatment
10:50
to
12:20
Auditorium II
Oral presentation session
Innovative health approaches
10:50
to
12:20
Auditorium III
Oral presentation session
Sex, gender and diversity in drugs
10:50
to
12:20
Auditorium IV
Oral presentation session
Advancing addiction research: global perspectives and collaborative initiatives
10:50
to
12:20
Auditorium VI
Oral presentation session
Lives at risk: mental health and substance use
10:50
to
12:20
Auditorium VII
Oral presentation session
Prevalence of opioids and related harms
10:50
to
12:20
Auditorium VIII
Oral presentation session
Mechanisms and outcomes in substance use prevention among youth
10:50
to
12:20
Room 5A
Oral presentation session
Gambling: work-related, financial, and criminological issues
10:50
to
12:20
Room 5B
Oral presentation session
Building addiction workforce capacity
10:50
to
12:20
Room 5C
Oral presentation session
Treatment of alcohol use disorder
10:50
to
12:20
Room 1.05
Short communication session
Support for recovery
10:50
to
12:20
Room 1.07
Short communication session
Alcohol: policy and harm reduction
10:50
to
12:20
Room 1.08
Short communication session
Closed session
ECR Programme — Scientific writing
10:50
to
12:20
Room 1.10
Workshop
Evaluation of drug consumption rooms: guidance step by step
10:50
to
12:20
Room 1.15
Workshop
12:20
Lunch break
12:20
to
13:20
Break
13:20
Enhancing access to harm reduction services in community and prisons: experiences of translating policy into practice and scaling interventions
13:20
to
14:50
Auditorium I
Major session
Alcohol use in the young
13:20
to
14:50
Auditorium II
Oral presentation session
Neuroscience and cognition
13:20
to
14:50
Auditorium III
Short communication session
Legal shifts and their Impact on drug use and sentencing
13:20
to
14:50
Auditorium IV
Oral presentation session
Drug policy and the criminal legal system
13:20
to
14:50
Auditorium VI
Oral presentation session
Tobacco, mental health and other substance use
13:20
to
14:50
Auditorium VII
Oral presentation session
Gender and substance use
13:20
to
14:50
Auditorium VIII
Oral presentation session
Substance use interventions in youth
13:20
to
14:50
Room 5A
Oral presentation session
Neurocognitive processes in behavioural addictions
13:20
to
14:50
Room 5B
Oral presentation session
Learning from Africa: workforce development, enhancement and support
13:20
to
14:50
Room 5C
Oral presentation session
Alcohol use disorder: clinical biology and epidemiology
13:20
to
14:50
Room 1.05
Short communication session
Meetings the needs of women who use drugs or alcohol
13:20
to
14:50
Room 1.06
Short communication session
Challenge of measuring use and impact of cannabinoids
13:20
to
14:50
Room 1.07
Oral presentation session
Methods and measurement
13:20
to
14:50
Room 1.08
Short communication session
The peer model: the critical role of ethics in efficacy
13:20
to
14:50
Room 1.15
Workshop
14:50
Break
14:50
to
15:00
Break
15:00
Challenges in community-based prevention
15:00
to
16:30
Auditorium I
Major session
Alcohol use from brief intervention to harm reduction
15:00
to
16:30
Auditorium II
Oral presentation session
The recovery journey
15:00
to
16:30
Auditorium III
Oral presentation session
Infectious diseases in people who inject drugs
15:00
to
16:30
Auditorium IV
Oral presentation session
Measuring drug market phenomenon
15:00
to
16:30
Auditorium VI
Oral presentation session
Substance use and psychosis
15:00
to
16:30
Auditorium VII
Oral presentation session
The growing threat of synthetic drugs – developments and responses in North America and Europe
15:00
to
16:30
Auditorium VIII
Oral presentation session
Surveillance of drug-related morbidity and mortality
15:00
to
16:30
Room 5A
Oral presentation session
Assessment of behavioural addictions
15:00
to
16:30
Room 5B
Oral presentation session
Inequalities and needs of migrant groups
15:00
to
16:30
Room 5C
Oral presentation session
Responses to behavioural addictions
15:00
to
16:30
Room 1.05
Short communication session
Quality in addictions work systems
15:00
to
16:30
Room 1.06
Oral presentation session
Problematic gambling and gaming
15:00
to
16:30
Room 1.07
Short communication session
Conceptualising health and harms
15:00
to
16:30
Room 1.08
Short communication session
Trauma and addiction - developing skills in the screening of traumatic experiences in addiction care
15:00
to
16:30
Room 1.10
Workshop
LEGO® SERIOUS PLAY® facilitated workshop optimal workplace and wellbeing in workers in addictions fields
15:00
to
16:30
Room 1.15
Workshop
WAVE Cine Video contest session 1: Showcasing innovative science and services
15:00
to
16:30
Room 1.09
Video contest
16:30
Coffee break
16:30
to
16:50
Break
16:50
The EUFAS-EAR European Addiction Research Award
16:50
to
18:20
Auditorium I
Major session
Strengthening quality in substance use disorders treatment
16:50
to
18:20
Auditorium II
Oral presentation session
NPS: trends, concerns and response strategies
16:50
to
18:20
Auditorium III
Oral presentation session
Drug use trends
16:50
to
18:20
Auditorium IV
Oral presentation session
Decriminalisation and alternatives to arrest
16:50
to
18:20
Auditorium VI
Oral presentation session
Understanding interrelationships: mental health and substance use
16:50
to
18:20
Auditorium VII
Oral presentation session
Psychedelics 1
16:50
to
18:20
Auditorium VIII
Oral presentation session
Novel and contextual approaches in prevention
16:50
to
18:20
Room 5A
Oral presentation session
Opioid treatment 1
16:50
to
18:20
Room 5B
Oral presentation session
Hepatitis C, HIV, and other drug related harms
16:50
to
18:20
Room 1.05
Short communication session
Opioids: trends, use and treatments
16:50
to
18:20
Room 1.06
Short communication session
Motivations for use
16:50
to
18:20
Room 5C
Oral presentation session
Showcasing AI and digital workforce support
16:50
to
18:20
Room 1.15
Workshop
Capacity-building through competencies for the substance use workforce
16:50
to
18:20
Room 1.07
Workshop
18:20
Break
18:20
to
18:30
Break
18:30
Why are we not doing better at reducing drug-related deaths?
18:30
to
19:30
Auditorium I
Big debate
Thu 24 Oct
09:00
Synthetic opioids and psychedelics: new opportunities & new challenges for clinical practice
Plenary session 2
09:00
to
10:30
Auditorium I
Plenary session
Workshop on conducting drug research in prison: Challenges and key recommendations from the European experience
09:00
to
10:30
Room 1.15
Workshop
Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.
09:00
to
10:30
Room 1.10
Workshop
e-poster session day 2
09:00
to
18:20
Digital kiosks
e-poster session
e-short communication session day 2
09:00
to
18:20
Digital kiosks
e-short communication session
10:30
Coffee break
10:30
to
10:50
Break
10:50
International collaboration to understand and address the co-occurrence of addiction with ADHD and autism spectrum disorders
10:50
to
12:20
Auditorium I
Major session
Predicting the future: biomarkers for progression of alcohol use disorder
10:50
to
12:20
Auditorium II
Oral presentation session
Contemporary issues
10:50
to
12:20
Room 1.08
Oral presentation session
Opioid Agonist Treatment: novel formulations and challenges
10:50
to
12:20
Auditorium IV
Oral presentation session
Evidence informed drug and alcohol policy
10:50
to
12:20
Auditorium VI
Oral presentation session
Emerging drug harms, DCRs and other responses
10:50
to
12:20
Auditorium VII
Short communication session
The challenges of the digital era: an interdisciplinary investigation of screen time and social media.
10:50
to
12:20
Auditorium VIII
Major session
Innovative methods for understanding drug markets and policy
10:50
to
12:20
Room 5A
Oral presentation session
Young people and comorbidity - alcohol, gambling and mental health
10:50
to
12:20
Room 5B
Oral presentation session
Opioid treatment 2
10:50
to
12:20
Auditorium III
Oral presentation session
Workers reaching marginalised groups
10:50
to
12:20
Room 5C
Oral presentation session
Challenges, threats, and opportunities in addiction publishing today
10:50
to
12:20
Room 1.05
Oral presentation session
Natural language processing for addiction research: a practical primer
10:50
to
12:20
Room 1.06
Workshop
EU research funding opportunities
10:50
to
12:20
Room 1.07
Workshop
Closed session
ECR Programme — An introduction to theory in qualitative research
10:50
to
12:20
Room 1.10
Workshop
Back-casting exercise on peer-support workforce development
10:50
to
12:20
Room 1.15
Workshop
12:20
Lunch break
12:20
to
13:20
Break
13:20
New opportunities for informing clinical practice and policy development in the area of behavioural addictions
13:20
to
14:50
Auditorium I
Major session
Novel neurobiology - cannabis, cognition and craving
13:20
to
14:50
Auditorium III
Oral presentation session
Conceptual frameworks for studying drug policy
13:20
to
14:50
Auditorium VI
Oral presentation session
Young people, mental health and substance use
13:20
to
14:50
Auditorium VII
Oral presentation session
Nitazene-related fatal and non-fatal toxicity in Europe: hospital emergency perspective
13:20
to
14:50
Auditorium VIII
Oral presentation session
Public health and safety impacts of cannabis legalization in Canada: five years in review
13:20
to
14:50
Auditorium IV
Oral presentation session
Hospital-based treatments
13:20
to
14:50
Room 5A
Oral presentation session
Pregnancy, drug use and care
13:20
to
14:50
Room 5B
Oral presentation session
Co-creating robust systems with workers
13:20
to
14:50
Room 5C
Oral presentation session
Understanding drug-related deaths
13:20
to
14:50
Room 1.07
Oral presentation session
Understanding harm reduction: economic, social, and health perspectives
13:20
to
14:50
Room 1.05
Short communication session
European prevention curriculum: increasing the use of evidence-based prevention
13:20
to
14:50
Room 1.06
Short communication session
Women's realities of drug use
13:20
to
14:50
Room 1.08
Oral presentation session
Scenarios for the future of addictions fields by 2040
13:20
to
14:50
Room 1.10
Workshop
Writing for 'addiction' journals for early career researchers with DEPP Editors-in-Chief
13:20
to
14:50
Room 1.15
Workshop
WAVE Cine Video contest session 2: Sharing insightful lived experience
13:20
to
14:50
Room 1.09
Video contest
14:50
Break
14:50
to
15:00
Break
15:00
New perspectives: AI as a tool to support the addictions workforce
15:00
to
16:30
Auditorium I
Major session
Alcohol epidemiology: social inequalities
15:00
to
16:30
Auditorium II
Oral presentation session
NPS: Pharmacological Characterization and Substance Analysis
15:00
to
16:30
Auditorium III
Oral presentation session
Hepatitis C testing and treatment
15:00
to
16:30
Auditorium IV
Oral presentation session
The hepatitis C endgame: Science, Policy, Politics
15:00
to
16:30
Auditorium VIII
Major session
Cannabis legalisation — models and impacts
15:00
to
16:30
Auditorium VI
Oral presentation session
How can treatment be a better experience?
15:00
to
16:30
Auditorium VII
Oral presentation session
Protective and risk factors in drug prevention
15:00
to
16:30
Room 5A
Oral presentation session
Policy issues in gambling
15:00
to
16:30
Room 5B
Oral presentation session
A unique care model for inpatient addictions and tri-morbidity within an acute UK hospital
15:00
to
16:30
Room 5C
Oral presentation session
Novel psychoactive substances and latest drug trends in Asia and Pacific countries
15:00
to
16:30
Room 1.05
Oral presentation session
From genes to brains
15:00
to
16:30
Room 1.06
Short communication session
City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction
15:00
to
16:30
Room 1.07
Workshop
Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain
15:00
to
16:30
Room 1.08
Oral presentation session
How to train an addiction specialist?
15:00
to
16:30
Room 1.10
Workshop
How to respond to real-time drug alerts in European countries ?
15:00
to
16:30
Room 1.15
Workshop
16:30
Coffee break
16:30
to
16:50
Break
16:50
How can the voices of people with lived experience, clients and communities impacted by drug use better inform clinical practice, research and the policy agenda?
16:50
to
17:50
Auditorium I
Big debate
Alcohol and gender issues
16:50
to
18:20
Auditorium II
Oral presentation session
Mixed methods for understanding drug use
16:50
to
18:20
Auditorium III
Oral presentation session
Viral hepatitis among people who inject drugs
16:50
to
18:20
Auditorium IV
Oral presentation session
Alcohol use from anxiety in the young to disability in the old
16:50
to
18:20
Auditorium VI
Oral presentation session
Substance use and mental health in treatment settings
16:50
to
18:20
Auditorium VII
Oral presentation session
Misuse of medicines
16:50
to
18:20
Auditorium VIII
Oral presentation session
New research on alcohol and tobacco policy
16:50
to
18:20
Room 5A
Oral presentation session
From old to new: changes in drug use
16:50
to
18:20
Room 5C
Oral presentation session
Behavioural addictions, prevention and theory
16:50
to
18:20
Room 1.05
Short communication session
Newly regulated markets, managing harms, treatment & advocating for reform
16:50
to
18:20
Room 1.06
Short communication session
Internet, smartphones and social media use
16:50
to
18:20
Room 1.07
Short communication session
ScaleUp: Options for scalable psychosocial and pharmacological treatment of stimulant use disorder
16:50
to
18:20
Room 1.08
Oral presentation session
A two-phased augmentation/intervention extension of Claremont’s media-based prevention education model
16:50
to
18:20
Room 1.10
Workshop
Toolkit to Deal with Female Drug User Victims of Gender-Based Violence
16:50
to
18:20
Room 1.15
Workshop
17:50
EUDA presentation
17:50
to
18:20
Auditorium I
Major session
18:20
Break
18:20
to
18:30
Break
18:30
EUDA launch networking dinner (for all conference participants)
18:30
to
21:30
Break
Fri 25 Oct
09:00
Joining the dots: the relationship between substance use and other health conditions
Plenary session 3
09:00
to
10:30
Auditorium I
Plenary session
A comparative discussion on the role, challenges, and opportunities for addiction nurses within Europe
09:00
to
10:30
Room 1.15
Workshop
e-poster session day 3
09:00
to
14:50
Digital kiosks
e-poster session
e-short communication session day 3
09:00
to
14:50
Digital kiosks
e-short communication session
10:30
Coffee break
10:30
to
10:50
Break
10:50
The ripple effect: International developments in the opioid market and their potential implications for European public health and security
10:50
to
12:20
Auditorium I
Major session
Alcohol: interventions and up-to-date technologies
10:50
to
12:20
Auditorium II
Oral presentation session
Gaming and social media use
10:50
to
12:20
Auditorium III
Oral presentation session
Intentional and non-intentional drug-related deaths
10:50
to
12:20
Auditorium IV
Oral presentation session
Psychedelics 2
10:50
to
12:20
Auditorium VI
Oral presentation session
Trauma and substance use
10:50
to
12:20
Auditorium VII
Oral presentation session
Unravelling the nexus: understanding drug-related violence across Europe
10:50
to
12:20
Auditorium VIII
Oral presentation session
Drugs checking services
10:50
to
12:20
Room 5A
Oral presentation session
Online monitoring
10:50
to
12:20
Room 5B
Oral presentation session
Substance use and treatment needs across European prisons
10:50
to
12:20
Room 5C
Oral presentation session
Emerging challenges in drug markets: monitoring, measurement & impacts
10:50
to
12:20
Room 1.05
Short communication session
Gaming and health
10:50
to
12:20
Room 1.06
Short communication session
Support for the addiction workforce
10:50
to
12:20
Room 1.07
Oral presentation session
How can cannabis policy goals inform the development of evaluation indicators?
10:50
to
12:20
Room 1.08
Workshop
Closed session
ECR Programme — EU research funding opportunities
10:50
to
12:20
Room 1.10
Workshop
Intimate partner violence perpetration: The ADVANCE-Digital Programme for men
10:50
to
12:20
Room 1.15
Workshop
WAVE Cine Video contest session 3: Journeys through addiction science and lived experience
10:50
to
12:20
Room 1.09
Video contest
12:20
Lunch break
12:20
to
13:20
Break
13:20
Findings from The Lancet Public Health Commission on Gambling: protecting the public from gambling harms
13:20
to
14:50
Auditorium I
Oral presentation session
Alcohol and other drug policies in the work setting – a perspective on European developments
13:20
to
14:50
Auditorium II
Oral presentation session
Young people and drugs
13:20
to
14:50
Auditorium III
Oral presentation session
Overdose prevention
13:20
to
14:50
Auditorium IV
Oral presentation session
Addressing diverse treatment needs
13:20
to
14:50
Auditorium VI
Oral presentation session
Substance use and mental health in prison settings
13:20
to
14:50
Auditorium VII
Oral presentation session
Regulating cannabis supply policies in Europe: navigating the long road to change
13:20
to
14:50
Auditorium VIII
Oral presentation session
Prevention and addiction in underrepresented groups
13:20
to
14:50
Room 5A
Oral presentation session
Impact of drug policy on drug production & markets
13:20
to
14:50
Room 5B
Oral presentation session
Holistic care for mental well-being
13:20
to
14:50
Room 1.05
Short communication session
Research into practice: The implementation and evaluation of alcohol assertive outreach treatment in England
13:20
to
14:50
Room 1.10
Workshop
Future of opioid markets in Europe: Foresight approaches
13:20
to
14:50
Room 1.10
Workshop
14:50
Break
14:50
to
15:00
Break
15:00
Future paradigms for drug markets and drug policies?
Closing session
15:00
to
16:40
Auditorium I
Plenary session
16:40
Closing ceremony
16:40
to
16:50
Auditorium I
Plenary session
Back to top